{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:36:19Z","timestamp":1769114179232,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11883-018-0757-3","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:29:42Z","timestamp":1537144182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure"],"prefix":"10.1007","volume":"20","author":[{"given":"Rose Mary Ferreira Lisboa","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anaisa Silva Roever","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilson Penha","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmiro Santos","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Roever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Biondi-Zoccai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"issue":"suppl_C","key":"757_CR1","doi-asserted-by":"publisher","first-page":"C4","DOI":"10.1093\/eurheartj\/sur014","volume":"13","author":"C Ceconi","year":"2011","unstructured":"Ceconi C, Guardigli G, Rizzo P, Francolini G, Ferrari R. The heart rate story. Eur Heart J Supplements. 2011;13(suppl_C):C4\u2013C13. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/sur014\n                      \n                    .","journal-title":"Eur Heart J Supplements"},{"issue":"7","key":"757_CR2","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/0735-1097(94)90177-5","volume":"24","author":"SM Ryan","year":"1994","unstructured":"Ryan SM, Goldberger AL, Pincus SM, Mietus J, Lipsitz LA. Gender- and age-related differences in heart rate dynamics: are women more complex than men? J Am CollCardiol. 1994;24(7):1700\u20137 \n                      https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7963118\n                      \n                    .","journal-title":"J Am CollCardiol."},{"issue":"9","key":"757_CR3","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.amjhyper.2005.04.009","volume":"18","author":"J YAMAGUCHI","year":"2005","unstructured":"Yamaguchi J, Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Ohmori K, et al. Factors affecting home-measured resting heart rate in the general population: the Ohasama study. Am J Hypertens. 2005;18(9 Pt 1):1218\u201325. \n                      https:\/\/doi.org\/10.1016\/j.amjhyper.2005.04.009\n                      \n                    .","journal-title":"American Journal of Hypertension"},{"issue":"11","key":"757_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/00004872-199917110-00013","volume":"7","author":"RH Fagard","year":"1999","unstructured":"Fagard RH, Pardaens K, Staessen JA. Influence of demographic, anthropometric and lifestyle characteristics on heart rate and its variability in the population. J Hypertens. 1999;7(11):1589\u201399 \n                      https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10608473\n                      \n                    .","journal-title":"J Hypertens"},{"issue":"3","key":"757_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cnc.2016.04.003","volume":"28","author":"Shu-Fen Wung","year":"2016","unstructured":"Wung SF. Bradyarrhythmias: clinical presentation, diagnosis, and management. Crit Care NursClin North Am. 2016; 28(3):297\u2013308. doi: \n                      https:\/\/doi.org\/10.1016\/j.cnc.2016.04.003\n                      \n                    .","journal-title":"Critical Care Nursing Clinics of North America"},{"key":"757_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neubiorev.2016.03.007","volume":"4","author":"J Koenig","year":"2016","unstructured":"Koenig J, Thayer JF. Sex differences in healthy human heart rate variability: a meta-analysis. NeurosciBiobehav Rev. 2016;4:288\u2013310. \n                      https:\/\/doi.org\/10.1016\/j.neubiorev.2016.03.007\n                      \n                    .","journal-title":"NeurosciBiobehav Rev"},{"issue":"2","key":"757_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.pharmthera.2005.10.016","volume":"111","author":"XJ Du","year":"2006","unstructured":"Du XJ, Fang L, Kiriazis H. Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms. PharmacolTher. 2006;111(2):434\u201375. \n                      https:\/\/doi.org\/10.1016\/j.pharmthera.2005.10.016\n                      \n                    .","journal-title":"PharmacolTher"},{"issue":"11Suppl","key":"757_CR8","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.hrthm.2009.07.017","volume":"6","author":"RL Verrier","year":"2009","unstructured":"Verrier RL, Tan A. Heart rate, autonomic markers, and cardiac mortality. Heart Rhythm. 2009;6(11Suppl):S68\u201375. \n                      https:\/\/doi.org\/10.1016\/j.hrthm.2009.07.017\n                      \n                    .","journal-title":"Heart Rhythm"},{"issue":"3","key":"757_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1085\/jgp.201010506","volume":"136","author":"HP Larsson","year":"2010","unstructured":"Larsson HP. How is the heart rate regulated in the sinoatrial node? Another piece to the puzzle. J Gen Physiol. 2010;136(3):237\u201341. \n                      https:\/\/doi.org\/10.1085\/jgp.201010506\n                      \n                    .","journal-title":"J Gen Physiol"},{"issue":"6","key":"757_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","volume":"113","author":"William B. Kannel","year":"1987","unstructured":"\u2022 Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987; 113(6):1489\u20131494.\n                      https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3591616\n                      \n                    . A classic study on the relationship between heart rate and cardiovascular mortality.","journal-title":"American Heart Journal"},{"issue":"3","key":"757_CR11","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.1503\/cmaj.15053","volume":"188","author":"D Zhang","year":"2016","unstructured":"Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ. 2016;188(3):E53\u201363. \n                      https:\/\/doi.org\/10.1503\/cmaj.15053\n                      \n                    .","journal-title":"CMAJ"},{"issue":"12","key":"757_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/ng.3708","volume":"48","author":"Ruben N Eppinga","year":"2016","unstructured":"Eppinga RN, Hagemeijer Y, Burgess S, Hinds DA, Stefansson K, Gudbjartsson DF, et al. Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality. Nat Genet. 2016;48(12):1557\u201363. \n                      https:\/\/doi.org\/10.1038\/ng.3708\n                      \n                    .","journal-title":"Nature Genetics"},{"issue":"1","key":"757_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/heartjnl-2016-310986","volume":"104","author":"MT Jensen","year":"2018","unstructured":"Jensen MT, Wod M, Galatius S, Hjelmborg JB, Jensen GB, Christensen K. Heritability of resting heart rate and association with mortality in middle-aged and elderly twins. Heart. 2018;104(1):30\u20136. \n                      https:\/\/doi.org\/10.1136\/heartjnl-2016-310986\n                      \n                    .","journal-title":"Heart"},{"issue":"3","key":"757_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jamacardio.2017.4974","volume":"3","author":"Ali Vazir","year":"2018","unstructured":"Vazir A, Claggett B, Cheng S, Skali H, Shah A, Agulair D, et al. In a community-based cohort, time-updated HR and \u0394HR are associated with mortality and nonfatal outcomes of incident HF, myocardial infarction, and stroke. Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. JAMA Cardiol. 2018;3(3):200\u20136. \n                      https:\/\/doi.org\/10.1001\/jamacardio.2017.4974\n                      \n                    .","journal-title":"JAMA Cardiology"},{"issue":"2","key":"757_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jamainternmed.2015.7655","volume":"176","author":"Ajay Dharod","year":"2016","unstructured":"Dharod A, Soliman EZ, Dawood F, Chen H, Shea S, Nazarian S, et al. Association of asymptomatic bradycardia with incident cardiovascular disease and mortality: the Multi-Ethnic Study of Atherosclerosis (MESA). JAMA Intern Med. 2016;176(2):219\u201327. \n                      https:\/\/doi.org\/10.1001\/jamainternmed.2015.7655\n                      \n                    .","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"757_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2011.06.033","volume":"220","author":"Jonathan Rubin","year":"2012","unstructured":"Rubin J, Blaha MJ, Budoff MJ, Rivera JJ, Shaw LJ, Blankstein R, et al. The relationship between resting heart rate and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2012;220(1):194\u2013200. \n                      https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.033\n                      \n                    .","journal-title":"Atherosclerosis"},{"key":"757_CR17","doi-asserted-by":"publisher","unstructured":"Ho JE, Larson MG, Ghorbani A, Cheng S, Coglianese EE, Vasan RS, et al. Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study. J Am Heart Assoc. 2014;3(3):e000668. \n                      https:\/\/doi.org\/10.1161\/JAHA.113.000668\n                      \n                    .","DOI":"10.1161\/JAHA.113.000668"},{"key":"757_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2018.04.004","volume":"273","author":"Kojo Amoakwa","year":"2018","unstructured":"Amoakwa K, Fashanu OE, Tibuakuu M, Zhao D, Guallar E, Whelton SP, et al. Resting heart rate and the incidence and progression of valvular calcium: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2018;273:45\u201352. \n                      https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.004\n                      \n                    .","journal-title":"Atherosclerosis"},{"issue":"7","key":"757_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrcardio.2011.58","volume":"8","author":"Kim M. Fox","year":"2011","unstructured":"\u2022 Fox KM, Ferrari R. Heart rate: a forgotten link in coronary artery disease? Nat Rev Cardiol. 2011;8(7):369\u201379. \n                      https:\/\/doi.org\/10.1038\/nrcardio.2011.58\n                      \n                    . \n                      https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21519356\n                      \n                     Article on link between heart rate and coronary atherosclerosis.","journal-title":"Nature Reviews Cardiology"},{"issue":"4","key":"757_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.amjcard.2013.11.009","volume":"113","author":"Seamus P. Whelton","year":"2014","unstructured":"Whelton SP, Narla V, Blaha MJ, Nasir K, Blumenthal RS, Jenny NS, et al. Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2014;113(4):644\u20139. \n                      https:\/\/doi.org\/10.1016\/j.amjcard.2013.11.009\n                      \n                    .","journal-title":"The American Journal of Cardiology"},{"issue":"12","key":"757_CR21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jacc.2013.11.027","volume":"63","author":"Anders Opdahl","year":"2014","unstructured":"Opdahl A, AmbaleVenkatesh B, Fernandes VR, Wu CO, Nasir K, Choi EY, et al. Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis). J Am CollCardiol. 2014;63(12):1182\u20139. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2013.11.027\n                      \n                    .","journal-title":"Journal of the American College of Cardiology"},{"issue":"9744","key":"757_CR22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","volume":"376","author":"Michael B\u00f6hm","year":"2010","unstructured":"B\u00f6hm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376:886\u201394. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(10)61259-7\n                      \n                    .","journal-title":"The Lancet"},{"issue":"10","key":"757_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/eurjhf\/hfs104","volume":"14","author":"R Pfister","year":"2012","unstructured":"Pfister R, Michels G, Sharp SJ, Luben R, Wareham NJ, Khaw KT. Resting heart rate and incident heart failure in apparently healthy men and women in the EPIC-Norfolk study. Eur J Heart Fail. 2012;14(10):1163\u201370. \n                      https:\/\/doi.org\/10.1093\/eurjhf\/hfs104\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"757_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1161\/CIRCHEARTFAILURE.112.000171","volume":"6","author":"D. Nanchen","year":"2013","unstructured":"Nanchen D, Leening MJ, Locatelli I, Cornuz J, Kors JA, Heeringa J, Deckers JW, Hofman A, Franco OH, Stricker BH, Witteman JC, Dehghan A. Resting heart rate and the risk of heart failure in healthy adults: the Rotterdam Study. Circ Heart Fail2013; 6(3):403\u2013410. doi: \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000171\n                      \n                    .","journal-title":"Circulation: Heart Failure"},{"issue":"2","key":"757_CR25","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.ijcard.2013.10.071","volume":"170","author":"Francisco J. Pastor-P\u00e9rez","year":"2013","unstructured":"Pastor-P\u00e9rez FJ, Manzano-Fern\u00e1ndez S, Goya-Esteban R, Pascual-Figal DA, Bravo IP, Barquero-P\u00e9rez O, et al. Heart rate control in chronic heart failure: resting versus mean heart rate with prolonged ambulatory ECG recording. Int J Cardiol. 2013;170(2):e45\u20137. \n                      https:\/\/doi.org\/10.1016\/j.ijcard.2013.10.071\n                      \n                    .","journal-title":"International Journal of Cardiology"},{"issue":"20","key":"757_CR26","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jacc.2011.12.044","volume":"59","author":"Davide Castagno","year":"2012","unstructured":"Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, et al. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am CollCardiol. 2012;59(20):785\u201395. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2011.12.044\n                      \n                    .","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"757_CR27","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1177\/2047487317708676","volume":"24","author":"WT O'Neal","year":"2017","unstructured":"O'Neal WT, Sandesara PB, Samman-Tahhan A, Kelli HM, Hammadah M, Soliman EZ. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction. Eur J PrevCardiol. 2017;24(11):1212\u20139. \n                      https:\/\/doi.org\/10.1177\/2047487317708676\n                      \n                    .","journal-title":"Eur J PrevCardiol"},{"issue":"15","key":"757_CR28","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.jacc.2017.08.022","volume":"70","author":"Phillip H. Lam","year":"2017","unstructured":"Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, et al. Heart rate and outcomes in hospitalized patients with heart failure with preserved ejection fraction. J Am CollCardiol. 2017;70(15):1861\u201371. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2017.08.022\n                      \n                    .","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"757_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jchf.2017.08.018","volume":"5","author":"Ali Vazir","year":"2017","unstructured":"Vazir A, Claggett B, Pitt B, Anand I, Sweitzer N, Fang J, et al. Prognostic importance of temporal changes in resting heart rate in heart failure and preserved ejection fraction: from the TOPCAT Study. JACC Heart Fail. 2017;S2213-1779(17):30602\u20139. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2017.08.018\n                      \n                    .","journal-title":"JACC: Heart Failure"},{"issue":"4","key":"757_CR30","doi-asserted-by":"publisher","first-page":"567-574.e6","DOI":"10.1016\/j.ahj.2013.01.007","volume":"165","author":"Anh L. Bui","year":"2013","unstructured":"Bui AL, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Yancy CW, Bhatt DL, et al. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. Am Heart J. 2013;165(4):567\u2013574.e6. \n                      https:\/\/doi.org\/10.1016\/j.ahj.2013.01.007\n                      \n                    .","journal-title":"American Heart Journal"},{"issue":"17","key":"757_CR31","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1161\/CIRCULATIONAHA.114.013709","volume":"132","author":"Tze-Fan Chao","year":"2015","unstructured":"Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, et al. Rate-control treatment and mortality in atrial fibrillation. Circulation. 2015;132(17):1604\u201312. \n                      https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013709\n                      \n                    .","journal-title":"Circulation"},{"key":"757_CR32","doi-asserted-by":"publisher","unstructured":"Steinberg BA, Kim S, Thomas L, Fonarow GC, Gersh BJ, Holmqvist F, et al. Increased heart rate is associated with higher mortality in patients with atrial fibrillation (AF): results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF). J Am Heart Assoc. 2015;4(9):e002031. \n                      https:\/\/doi.org\/10.1161\/JAHA.115.002031\n                      \n                    .","DOI":"10.1161\/JAHA.115.002031"},{"issue":"27","key":"757_CR33","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Piotr Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors\/Task Force Members. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J2016; 37(27):2129\u20132200. doi: \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehw128\n                      \n                    .","journal-title":"European Heart Journal"},{"issue":"2","key":"757_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.amjcard.2010.02.031","volume":"106","author":"Marcelo C. Shibata","year":"2010","unstructured":"Shibata MC, Le\u00f3n H, Chatterley T, Dorgan M, Vandermeer B. Do calcium channel blockers increase the diagnosis of heart failure in patients with hypertension? Am J Cardiol. 2010; 106(2):228\u2013235. doi: \n                      https:\/\/doi.org\/10.1016\/j.amjcard.2010.02.031\n                      \n                    .","journal-title":"The American Journal of Cardiology"},{"issue":"4","key":"757_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10741-012-9347-6","volume":"18","author":"M Guglin","year":"2013","unstructured":"Guglin M. Heart rate reduction in heart failure: ivabradine or beta blockers? Heart Fail Rev. 2013;18(4):517\u201328. \n                      https:\/\/doi.org\/10.1007\/s10741-012-9347-6\n                      \n                    .","journal-title":"Heart Fail Rev"},{"issue":"5","key":"757_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40256-017-0221-8","volume":"17","author":"CA D\u00e9zsi","year":"2017","unstructured":"D\u00e9zsi CA, Szentes V. The real role of \u03b2-blockers in daily cardiovascular therapy. Am J Cardiovasc Drugs. 2017;17(5):361\u201373. \n                      https:\/\/doi.org\/10.1007\/s40256-017-0221-8\n                      \n                    .","journal-title":"Am J Cardiovasc Drugs"},{"key":"757_CR37","doi-asserted-by":"publisher","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation2017; 136(6):e137-e161. doi: \n                      https:\/\/doi.org\/10.1161\/CIR.0000000000000509\n                      \n                    .","DOI":"10.1161\/CIR.0000000000000509"},{"issue":"2","key":"757_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jchf.2015.10.008","volume":"4","author":"Frank Edelmann","year":"2016","unstructured":"Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, et al. Tolerability and feasibility of beta-blocker titration in HFpEF versus HFrEF: insights from the CIBIS-ELD Trial. JACC Heart Fail. 2016;4(2):140\u20139. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2015.10.008\n                      \n                    .","journal-title":"JACC: Heart Failure"},{"issue":"10","key":"757_CR39","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","volume":"103","author":"Philippe Lechat","year":"2001","unstructured":"Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation. 2001;103(10):1428\u201333 \n                      https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11245648\n                      \n                    .","journal-title":"Circulation"},{"issue":"2","key":"757_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2004.10.032","volume":"45","author":"Lars Gullestad","year":"2005","unstructured":"Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, et al. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release\/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am CollCardiol. 2005;45(2):252\u20139. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2004.10.032\n                      \n                    .","journal-title":"Journal of the American College of Cardiology"},{"issue":"24","key":"757_CR41","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","volume":"69","author":"Dipak Kotecha","year":"2017","unstructured":"Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, et al. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am CollCardiol. 2017;69(24):2885\u201396. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2017.04.001\n                      \n                    .","journal-title":"Journal of the American College of Cardiology"},{"key":"757_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ahj.2015.10.026","volume":"173","author":"Adam D. DeVore","year":"2016","unstructured":"DeVore AD, Mi X, Mentz RJ, Fonarow GC, Van Dyke MK, Maya JF, et al. Discharge heart rate and \u03b2-blocker dose in patients hospitalized with heart failure: findings from the OPTIMIZE-HF registry. Am Heart J. 2016;173:172\u20138. \n                      https:\/\/doi.org\/10.1016\/j.ahj.2015.10.026\n                      \n                    .","journal-title":"American Heart Journal"},{"issue":"11","key":"757_CR43","doi-asserted-by":"publisher","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","volume":"150","author":"FA McAlister","year":"2009","unstructured":"McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150(11):784\u201394 \n                      https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19487713\n                      \n                    .","journal-title":"Ann Intern Med"},{"issue":"1","key":"757_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","volume":"39","author":"John G F Cleland","year":"2017","unstructured":"\u2022\u2022 Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018;39(1):26\u201335. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehx564\n                      \n                     Recent meta-analysis on the benefit of beta-blocker in heart failure.","journal-title":"European Heart Journal"},{"issue":"9961","key":"757_CR45","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","volume":"384","author":"Dipak Kotecha","year":"2014","unstructured":"Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD; Beta-Blockers in Heart Failure Collaborative Group. Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet2014; 384(9961):2235\u20132243. doi: \n                      https:\/\/doi.org\/10.1016\/S0140-6736(14)61373-8\n                      \n                    .","journal-title":"The Lancet"},{"issue":"12","key":"757_CR46","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrcardio.2014.166","volume":"11","author":"Paul Khairy","year":"2014","unstructured":"Khairy P, Roy D. Atrial fibrillation: challenging the status quo: \u03b2-blockers for HF plus AF. Nat Rev Cardiol2014; 11(12):690\u2013692. doi: \n                      https:\/\/doi.org\/10.1038\/nrcardio.2014.166\n                      \n                    .","journal-title":"Nature Reviews Cardiology"},{"key":"757_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2015.03.431","volume":"188","author":"D Long","year":"2015","unstructured":"Long D, Xiao Y, Dong B, Zhou S, Liu Q. Being cast into the shade of \u03b2 blockers for concomitant heart failure and atrial fibrillation? Int J Cardiol. 2015;188:35. \n                      https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.431\n                      \n                    .","journal-title":"Int J Cardiol"},{"issue":"2","key":"757_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jchf.2016.10.015","volume":"5","author":"Julia Cadrin-Tourigny","year":"2017","unstructured":"Cadrin-Tourigny J, Shohoudi A, Roy D, Talajic M, Tadros R, Mond\u00e9sert B, et al. Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: an AF-CHF substudy. JACC Heart Fail. 2017;5(2):99\u201310. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2016.10.015\n                      \n                    .","journal-title":"JACC: Heart Failure"},{"issue":"19","key":"757_CR49","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/heartjnl-2016-310391","volume":"103","author":"CA Martin","year":"2017","unstructured":"Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart. 2017;103(19):1543\u201352. \n                      https:\/\/doi.org\/10.1136\/heartjnl-2016-310391\n                      \n                    .","journal-title":"Heart"},{"issue":"10","key":"757_CR50","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.amjcard.2018.01.037","volume":"121","author":"Weijia Wang","year":"2018","unstructured":"Wang W, Alonso A, Soliman EZ, O\u2019Neal WT, Calkins H, Chen LY, et al. Relation of resting heart rate to incident atrial fibrillation (from ARIC [Atherosclerosis Risk in Communities] Study). Am J Cardiol. 2018;121(10):1169\u201376. \n                      https:\/\/doi.org\/10.1016\/j.amjcard.2018.01.037\n                      \n                    .","journal-title":"The American Journal of Cardiology"},{"issue":"14","key":"757_CR51","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jacc.2017.08.038","volume":"70","author":"JS Koruth","year":"2017","unstructured":"\u2022\u2022 Koruth JS, Lala A, Pinney S, Reddy VY, Dukkipati SR. The clinical use of ivabradine. J Am CollCardiol. 2017;70(14):1777\u201384. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2017.08.038\n                      \n                     Review ivabradine.","journal-title":"J Am CollCardiol"},{"issue":"9641","key":"757_CR52","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","volume":"372","author":"Kim Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008;372:817\u201321. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(08)61171-X\n                      \n                    .","journal-title":"The Lancet"},{"issue":"9744","key":"757_CR53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"Karl Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Lancet 2010; 376(9744):875\u201385. doi: \n                      https:\/\/doi.org\/10.1016\/S0140-6736(10)61198-1\n                      \n                    .","journal-title":"The Lancet"},{"issue":"12","key":"757_CR54","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","volume":"371","author":"Kim Fox","year":"2014","unstructured":"Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, et al. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med. 2014;371(12):1091\u20139. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1406430\n                      \n                    .","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"757_CR55","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","volume":"32","author":"Jean-Claude Tardif","year":"2011","unstructured":"Tardif JC, O\u2019Meara E, Komajda M, Bohm M, Borer JS, Ford I, et al. Effects of selective heart rate reduction with Ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J. 2011;32(20):2507\u201315. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehr311\n                      \n                    .","journal-title":"European Heart Journal"},{"key":"757_CR56","doi-asserted-by":"publisher","unstructured":"Das D, Savarese G, Dahlstr\u00f6m U, Fu M, Howlett J, Ezekowitz JA, et al. Ivabradine in heart failure: the representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a broad population of patients with chronic heart failure. Circ Heart Fail. 2017;10(9):e004112. \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004112\n                      \n                    .","DOI":"10.1161\/CIRCHEARTFAILURE.117.004112"},{"issue":"12","key":"757_CR57","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.amjcard.2015.09.029","volume":"116","author":"Michael B\u00f6hm","year":"2015","unstructured":"B\u00f6hm M, Robertson M, Ford I, Borer JS, Komajda M, Kindermann I, et al. Influence of cardiovascular and noncardiovascular co-morbidities on outcomes and treatment effect of heart rate reduction with Ivabradine in stable heart failure (from the SHIFT Trial). Am J Cardiol. 2015;116(12):1890\u20137. \n                      https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.029\n                      \n                    .","journal-title":"The American Journal of Cardiology"},{"issue":"11","key":"757_CR58","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"Paulus Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609\u201378. \n                      https:\/\/doi.org\/10.1093\/europace\/euw295\n                      \n                    .","journal-title":"Europace"},{"issue":"12","key":"757_CR59","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.amjmed.2015.06.016","volume":"128","author":"GA Ewy","year":"2015","unstructured":"Ewy GA. Digoxin: the art and science. Am J Med. 2015;128(12):1272\u20134. \n                      https:\/\/doi.org\/10.1016\/j.amjmed.2015.06.016\n                      \n                    .","journal-title":"Am J Med"},{"issue":"27","key":"757_CR60","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/eurheartj\/ehw577","volume":"38","author":"U Bavendiek","year":"2017","unstructured":"Bavendiek U, Aguirre Davila L, Koch A, Bauersachs J. Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure. Eur Heart J. 2017;38(27):2095\u20139. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehw577\n                      \n                    .","journal-title":"Eur Heart J"},{"issue":"10","key":"757_CR61","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jacc.2017.12.060","volume":"71","author":"Renato D. Lopes","year":"2018","unstructured":"Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators. Digoxin and mortality in patients with atrial fibrillation. J Am CollCardiol 2018; 71(10):1063\u20131074. doi: \n                      https:\/\/doi.org\/10.1016\/j.jacc.2017.12.060\n                      \n                    .","journal-title":"Journal of the American College of Cardiology"},{"key":"757_CR62","unstructured":"Evaluating different rate control therapies in permanent atrial fibrillation: a prospective, randomised, open-label, blinded endpoint feasibility pilot comparing digoxin and beta-blockers as initial rate control therapy. \n                      https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02391337"},{"issue":"11","key":"757_CR63","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/cvr\/cvx142","volume":"113","author":"CM Ripplinger","year":"2017","unstructured":"Ripplinger CM. From drugs to devices and back again: chemical vagal nerve stimulation for the treatment of heart failure. Cardiovasc Res. 2017;113(11):1270\u20132. \n                      https:\/\/doi.org\/10.1093\/cvr\/cvx142\n                      \n                    .","journal-title":"Cardiovasc Res"},{"key":"757_CR64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2017.06.036","volume":"244","author":"Gaetano M. De Ferrari","year":"2017","unstructured":"De Ferrari GM, Stolen C, Tuinenburg AE, Wright DJ, Brugada J, Butter C, et al. Long-term vagal stimulation for heart failure: eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial. Int J Cardiol. 2017;244:229\u201334. \n                      https:\/\/doi.org\/10.1016\/j.ijcard.2017.06.036\n                      \n                    .","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"757_CR65","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cjca.2017.01.022","volume":"33","author":"JL Reed","year":"2017","unstructured":"Reed JL, Blais AZ, Keast ML, Pipe AL, Reid RD. Performance of fixed heart rate increment targets of 20 vs 30 beats per minute for exercise rehabilitation prescription in outpatients with heart failure. Can J Cardiol. 2017;33(6):777\u201384. \n                      https:\/\/doi.org\/10.1016\/j.cjca.2017.01.022\n                      \n                    .","journal-title":"Can J Cardiol"},{"key":"757_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ctcp.2016.03.007","volume":"23","author":"AR Cole","year":"2016","unstructured":"Cole AR, Wijarnpreecha K, Chattipakorn SC, Chattipakorn N. Effects of Tai Chi exercise on heart rate variability. Complement TherClinPract. 2016;23:59\u201363. \n                      https:\/\/doi.org\/10.1016\/j.ctcp.2016.03.007\n                      \n                    .","journal-title":"Complement TherClinPract"},{"issue":"3","key":"757_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10484-015-9291-z","volume":"40","author":"P Posadzki","year":"2015","unstructured":"Posadzki P, Kuzdzal A, Lee MS, Ernst E. Yoga for heart rate variability: a systematic review and meta-analysis of randomized clinical trials. Appl Psychophysiol Biofeedback. 2015;40(3):239\u201349. \n                      https:\/\/doi.org\/10.1007\/s10484-015-9291-z\n                      \n                    .","journal-title":"Appl Psychophysiol Biofeedback"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-018-0757-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-018-0757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-018-0757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T19:15:47Z","timestamp":1568661347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-018-0757-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s11883-018-0757-3","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"17 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Rose Mary Ferreira Lisboa da Silva, Anaisa Silva Roever Borges, Nilson Penha Silva, Elmiro Santos Resende, Gary Tse, Tong Liu, Leonardo Roever, and Giuseppe Biondi-Zoccai declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"54"}}